Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Mehra

Showing results (231-240 of 347) with videos related to

Pageof 35
Sort By:
Cancer Research|July 1, 2010
Nrdp1-mediated regulation of ErbB3 expression by the androgen receptor in androgen-dependent but not castrate-resistant prostate cancer cellsLiqun Chen, Salma Siddiqui, Swagata Bose, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 3, 2009
AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonistDaniel R Rhodes, Bushra Ateeq, Qi Cao, et al.
Cancer Research|September 7, 2007
Integrative analysis of genomic aberrations associated with prostate cancer progressionJung H Kim, Saravana M Dhanasekaran, Rohit Mehra, et al.
The American Journal of Surgical Pathology|May 2, 2015
Diagnosis of Gleason pattern 5 prostate adenocarcinoma on core needle biopsy: an interobserver reproducibility study among urologic pathologistsRajal B Shah, Jianbo Li, Liang Cheng, et al.
Urology|June 25, 2014
Understanding the relationship between tumor size, gland size, and disease aggressiveness in men with prostate cancerMichael A Kozminski, Ganesh S Palapattu, Rohit Mehra, et al.
Molecular Cancer Research : MCR|October 14, 2017
miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer ProgressionBalabhadrapatruni V S K Chakravarthi, Darshan S Chandrashekar, Sumit Agarwal, et al.
Histopathology|December 24, 2022
Clear cell renal cell carcinoma with focal psammomatous calcifications: a rare occurrence mimicking translocation carcinomaAnkur R Sangoi, Khaleel I Al-Obaidy, Liang Cheng, et al.
Histopathology|February 7, 2017
A distinctive, low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase-deficient renal cell carcinomaSteven C Smith, Deepika Sirohi, Chisato Ohe, et al.
Neoplasia (New York, N.Y.)|October 28, 2008
Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancerSooryanarayana Varambally, Bharathi Laxman, Rohit Mehra, et al.
The American Journal of Surgical Pathology|February 23, 2016
Fumarate Hydratase-deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma SyndromeKiril Trpkov, Ondrej Hes, Abbas Agaimy, et al.
Pageof 35

Showing results (231-240 of 347) with videos related to

Sort By:
Pageof 35
Cancer Research|July 1, 2010
Nrdp1-mediated regulation of ErbB3 expression by the androgen receptor in androgen-dependent but not castrate-resistant prostate cancer cellsLiqun Chen, Salma Siddiqui, Swagata Bose, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 3, 2009
AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonistDaniel R Rhodes, Bushra Ateeq, Qi Cao, et al.
Cancer Research|September 7, 2007
Integrative analysis of genomic aberrations associated with prostate cancer progressionJung H Kim, Saravana M Dhanasekaran, Rohit Mehra, et al.
The American Journal of Surgical Pathology|May 2, 2015
Diagnosis of Gleason pattern 5 prostate adenocarcinoma on core needle biopsy: an interobserver reproducibility study among urologic pathologistsRajal B Shah, Jianbo Li, Liang Cheng, et al.
Urology|June 25, 2014
Understanding the relationship between tumor size, gland size, and disease aggressiveness in men with prostate cancerMichael A Kozminski, Ganesh S Palapattu, Rohit Mehra, et al.
Molecular Cancer Research : MCR|October 14, 2017
miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer ProgressionBalabhadrapatruni V S K Chakravarthi, Darshan S Chandrashekar, Sumit Agarwal, et al.
Histopathology|December 24, 2022
Clear cell renal cell carcinoma with focal psammomatous calcifications: a rare occurrence mimicking translocation carcinomaAnkur R Sangoi, Khaleel I Al-Obaidy, Liang Cheng, et al.
Histopathology|February 7, 2017
A distinctive, low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase-deficient renal cell carcinomaSteven C Smith, Deepika Sirohi, Chisato Ohe, et al.
Neoplasia (New York, N.Y.)|October 28, 2008
Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancerSooryanarayana Varambally, Bharathi Laxman, Rohit Mehra, et al.
The American Journal of Surgical Pathology|February 23, 2016
Fumarate Hydratase-deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma SyndromeKiril Trpkov, Ondrej Hes, Abbas Agaimy, et al.
Pageof 35